2015
DOI: 10.1007/s12035-015-9165-7
|View full text |Cite
|
Sign up to set email alerts
|

Metabolomic Analysis Reveals Increased Aerobic Glycolysis and Amino Acid Deficit in a Cellular Model of Amyotrophic Lateral Sclerosis

Abstract: Defects in energy metabolism are potential pathogenic mechanisms in amyotrophic lateral sclerosis (ALS), a rapidly fatal disease with no cure. The mechanisms through which this occurs remain elusive and their understanding may prove therapeutically useful. We used metabolomics and stable isotope tracers to examine metabolic changes in a well-characterized cell model of familial ALS, the motor neuronal NSC-34 line stably expressing human wild-type Cu/Zn superoxide dismutase (wtSOD1) or mutant G93A (G93ASOD1). O… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
51
0
6

Year Published

2016
2016
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 66 publications
(61 citation statements)
references
References 59 publications
4
51
0
6
Order By: Relevance
“…The low toxicity might also reflect the specific cell type used (motoneurons) that can survive under extreme conditions ( e.g. neurodegenerative conditions) due to their neuroprotective mechanisms (Maier et al, 2013b; Valbuena et al, 2016). …”
Section: Discussionmentioning
confidence: 99%
“…The low toxicity might also reflect the specific cell type used (motoneurons) that can survive under extreme conditions ( e.g. neurodegenerative conditions) due to their neuroprotective mechanisms (Maier et al, 2013b; Valbuena et al, 2016). …”
Section: Discussionmentioning
confidence: 99%
“…Aerobic glycolysis and the induction of one or more PDKs has also emerged as potential therapeutic targets for DCA in chronic inflammatory states associated with autoimmune disease (Gerriets, et al, 2016; Gerriets, et al, 2015), obstructive pulmonary disease (Calvert, et al, 2008; Mercken, et al, 2009; Ostroukhova, et al, 2012), coronary artery restenosis (Deuse, et al, 2014) and amyotrophic lateral sclerosis (ALS) (Miquel, et al, 2012; Palamiuc, et al, 2015; Valbuena, et al, 2016). Mouse models of ALS, due to mutations in Cu/Zn superoxide dismutase (SOD), have described the occurrence of a metabolic shift towards aerobic glycolysis, with upregulation of PDK and phosphorylation of PDC.…”
Section: Therapeutic Uses Of Dcamentioning
confidence: 99%
“…A recent metabolomics study identified alterations characteristic of an increased glycolysis and lipolysis in order to produce more adenosine triphosphate (ATP) and thus to facilitate energy consuming processes [97]. This overall increase in energy demand reflects major cellular activity in an atempt to control the ALS neurodegenerative process taking place and to activate CNS and muscle repair.…”
Section: Energy Metabolism and Nutrition In Alsmentioning
confidence: 99%